Simon M Ametamey Selected Research

Simon M Ametamey Research Topics

Disease

30	Neoplasms (Cancer) 10/2021 - 10/2004
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2013
7	Atherosclerotic Plaque (Atheroma) 04/2017 - 03/2006
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2012
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022 - 09/2013
4	Tobacco Use Disorder (Nicotine Dependence) 11/2019 - 01/2013
3	Nervous System Diseases (Neurological Disorders) 11/2019 - 05/2012
3	Neuroinflammatory Diseases 01/2019 - 03/2015
3	Inflammation (Inflammations) 01/2015 - 04/2012
3	Rupture 08/2014 - 06/2013
3	Autoimmune Diseases (Autoimmune Disease) 01/2014 - 04/2012
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2018
2	Sleep Deprivation 10/2019 - 01/2013
2	Atherosclerosis 04/2017 - 01/2013
2	Schizophrenia (Dementia Praecox) 01/2017 - 05/2012
2	Infections 01/2016 - 10/2004
2	Brain Diseases (Brain Disorder) 05/2015 - 05/2010
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2014 - 01/2013
2	Multiple Sclerosis 03/2014 - 09/2013
2	Osteosarcoma (Osteogenic Sarcoma) 08/2013 - 03/2006
2	Major Depressive Disorder (Major Depressive Disorders) 01/2013 - 07/2011
2	Abscess 03/2006 - 03/2004
2	Soft Tissue Infections 10/2004 - 03/2004
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2022
1	Brain Ischemia (Cerebral Ischemia) 10/2022
1	Stroke (Strokes) 01/2022
1	Mood Disorders (Mood Disorder) 10/2020
1	Bulimia Nervosa 01/2020
1	Dementia (Dementias) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Alcoholism (Alcohol Abuse) 10/2018
1	Huntington Disease (Huntington's Disease) 02/2018
1	Insulinoma 01/2018
1	Substance-Related Disorders (Drug Abuse) 03/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2016
1	Cognitive Dysfunction 04/2015
1	Shock 03/2015

Drug/Important Bio-Agent (IBA)

12	Folic Acid (Vitamin M)FDA LinkGeneric 10/2021 - 07/2006
8	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2022 - 01/2019
8	Metabotropic Glutamate 5 ReceptorIBA 01/2020 - 07/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2010
5	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 05/2010
5	Biological ProductsIBA 02/2018 - 01/2013
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2018 - 03/2014
4	Tyrosine (L-Tyrosine)FDA Link 01/2016 - 01/2013
4	Tryptophan (L-Tryptophan)FDA Link 01/2016 - 03/2012
4	Amino Acids FDA Link 01/2016 - 03/2012
4	AcidsIBA 01/2014 - 07/2006
4	BombesinIBA 10/2013 - 09/2008
4	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 08/2010
3	Pharmaceutical PreparationsIBA 11/2019 - 03/2006
3	Nicotine FDA Link 11/2019 - 01/2013
3	Peptides (Polypeptides)IBA 01/2018 - 02/2011
3	SiliconIBA 01/2018 - 09/2008
3	RadiopharmaceuticalsIBA 01/2016 - 04/2012
3	(18F)fluoroethyltyrosineIBA 01/2016 - 01/2013
3	CB2 Cannabinoid ReceptorIBA 05/2015 - 09/2013
3	fluoromisonidazoleIBA 08/2013 - 07/2005
3	Bombesin Receptors (Bombesin Receptor)IBA 02/2011 - 09/2008
2	CannabinoidsIBA 10/2022 - 09/2013
2	Fluorine-18IBA 01/2020 - 01/2013
2	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 01/2020 - 08/2009
2	LipopolysaccharidesIBA 01/2019 - 03/2015
2	Proteins (Proteins, Gene)FDA Link 02/2018 - 01/2015
2	ApolipoproteinsIBA 04/2017 - 04/2015
2	Protein Isoforms (Isoforms)IBA 01/2016 - 04/2012
2	AlbuminsIBA 01/2016 - 12/2013
2	Aromatic-L-Amino-Acid DecarboxylasesIBA 01/2016 - 03/2012
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2006 - 10/2004
2	fluoromethylcholineIBA 03/2006 - 03/2004
1	Ketamine FDA LinkGeneric 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	5,11-methenyltetrahydrohomofolateIBA 10/2021
1	Folate Receptor 1IBA 04/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2020
1	AminesIBA 11/2019
1	PSS232IBA 11/2019
1	Protons (Proton)IBA 10/2019
1	gamma-Aminobutyric Acid (GABA)IBA 10/2019
1	Glutamine (L-Glutamine)FDA Link 10/2019
1	Glutathione (Reduced Glutathione)IBA 10/2019
1	Choline (Choline Chloride)IBA 10/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2019
1	Butyric Acid (Butanoic Acid)IBA 10/2019
1	N-acetylaspartate (N-acetyl aspartate)IBA 10/2019
1	LigandsIBA 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 10/2018
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2018
1	Exenatide (Byetta)FDA Link 01/2018
1	Apolipoproteins E (ApoE)IBA 04/2017
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	EnzymesIBA 01/2016
1	EndocannabinoidsIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 04/2015
1	NitrogenIBA 03/2015
1	fibroblast activation protein alphaIBA 01/2015

Therapy/Procedure

9	Therapeutics 10/2021 - 10/2004